In a two-step, 7-day culture system, Ghamlouch et al. showed that CLL B-cells can differentiate into CD20+ plasmablasts/ASPCs when stimulated with a combination of CpG, CD40 ligand, and cytokines (14). The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.